Reports

Ideas That Generate Results

German Pharma Sector Analysis

German Pharma Sector Analysis

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Apr, 2010| No. of Pages : 30

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 600.00  250.00
CD-ROM Mail Delivery
US$ 700.00  300.00
Hard Copy Mail Delivery
US$ 700.00  350.00
Electronic Access - Multi-User License
US$ 1000.00  400.00

List of Figures:

Figure 3-1: Leading Causes of Death (%), 2009
Figure 4-1: Pharmaceutical Market (Billion Euro), 2008-2012
Figure 4-2: Branded Drugs Market (Billion Euro), 2008-2012
Figure 4-3: Generic Drugs Market (Billion Euro), 2008-2012
Figure 4-4: Share of Branded and Generic Drugs in Pharmaceutical Market (Value Terms), 2009
Figure 4-5: Share of Branded and Generic Drugs in Pharmaceutical Market (Volume Terms), 2009
Figure 4-6: Share of Export in Total Pharmaceutical Market (2009)

List of Tables:

Table 7-1: Recent M&As in Pharmaceutical Market
Table 7-2: Bayer Schering Pharma - Strengths & Weaknesses
Table 7-3: Pfizer Inc. - Strengths & Weaknesses
Table 7-4: Boehringer Ingelheim - Strengths & Weaknesses
Table 7-5: Abbott Laboratories - Strengths & Weaknesses
Table 7-6: Novartis - Strengths & Weaknesses

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.